IDO1 and neoplasm: Additionally, 2,4-diamino-6-hydroxypyrimidine (DAHP)-mediated suppression of GCH1 lowered IDO1 expression, inhibited tumor growth, and improved tumor response to PD-1 blocking immunotherapy.73